cerew

Cerevel Therapeutics Completes Redemption of Public Warrants (NASDAQ: CERE, CEREW) -END

Cerevel Therapeutics (Nasdaq: CERE; CEREW) (the “Company”), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today announced that on August 30, 2021 at 5:00 p.m. ET, it will redeem all of its outstanding public warrants to purchase shares of the Company’s common stock that were issued under the Warrant Agreement, […]

Cerevel Therapeutics Completes Redemption of Public Warrants (NASDAQ: CERE, CEREW) -END Read More »

Cerevel Therapeutics Announces Redemption of Public Warrants (NASDAQ: CERE, CEREW)

Cerevel Therapeutics (Nasdaq: CERE; CEREW) (the “Company”), a company dedicated to unraveling the mysteries of the brain to treat neuroscience diseases, today announced that on August 30, 2021 at 5:00 p.m. ET, it will redeem all of its outstanding public warrants to purchase shares of the Company’s common stock that were issued under the Warrant Agreement,

Cerevel Therapeutics Announces Redemption of Public Warrants (NASDAQ: CERE, CEREW) Read More »

Scroll to Top